The Microtubule-associated Protein Tau Is Extensively Modified with O-linked N-acetylglucosamine

Cited by (364)

Items 201–300 of 364

1. Brain O-GlcNAcylation: Bridging physiological functions, disease mechanisms, and therapeutic applications
   Chen, Liping, Jiang, Huihui, Licinio, Julio, Wu, Haitao · 2025 · Molecular Psychiatry
2. Inhibition of O-linked N-acetylglucosamine transferase activity in PC12 cells – A molecular mechanism of organophosphate flame retardants developmental neurotoxicity
   Yu‐Xin Gu, Yu Yang, Bin Wan, Minjie Li, Liang‐Hong Guo · 2018 · Biochemical Pharmacology
3. GFPT2/GFAT2 and AMDHD2 act in tandem to control the hexosamine pathway
   Virginia Kroef, Sabine Ruegenberg, Moritz Horn, Kira Allmeroth, Lena K. Ebert, Seyma Bozkus, Stephan Miethe, Ulrich Elling, Bernhard Schermer, Ulrich Baumann et al. · 2022 · Kölner Universitäts PublikationsServer (Universität zu Köln)
4. Selective decrease of membrane-associated PKC-α and PKC-ε in response to elevated intracellular O-GlcNAc levels in transformed human glial cells
   Jason A. Matthews, Mildred E. Acevedo-Duncan, Robert Lyman Potter · 2004 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
5. Evidence of traumatic brain injury in headbutting bovids
   Nicole L. Ackermans, Merina Varghese, Terrie M. Williams, Nicholas Grimaldi, Enna Selmanovic, Akbar Alipour, Priti Balchandani, Joy S. Reidenberg, Patrick R. Hof · 2022 · Acta Neuropathologica
6. O-GlcNAcylation of Neuronal Proteins: Roles in Neuronal Functions and in Neurodegeneration
   Olof Lagerlöf, Gerald Warren Hart · 2014 · Advances in neurobiology
7. Protein-Protein Interactions and Aggregation Inhibitors in Alzheimer’s Disease
   Ganeshpurkar, Ankit, Swetha, Rayala, Kumar, Devendra, Gangaram, Gore P., Singh, Ravi, Gutti, Gopichand, Jana, Srabanti, Kumar, Dileep, Kumar, Ashok, Singh, Sushil K. · 2019 · Current Topics in Medicinal Chemistry
8. Complicated Role of Post-translational Modification and Protease-Cleaved Fragments of Tau in Alzheimer’s Disease and Other Tauopathies
   Jie Yang, Naiting Shen, Jianying Shen, Ying Yang, Hong-Lian Li · 2023 · Molecular Neurobiology
9. A Novel Post-translational Modification in Nerve Terminals: O-Linked N -Acetylglucosamine Phosphorylation
   Mark Evan Graham, Morten Thaysen‐Andersen, Nicolai Bache, George E. Craft, Martin R. Larsen, Nicolle H. Packer, Phillip James Robinson · 2011 · Journal of Proteome Research
10. SIRT1 regulates O-GlcNAcylation of tau through OGT
    Shu Lu, Xiaomin Yin, Jia Wang, Qun Gu, Qin Huang, Nana Jin, Dandan Chu, Ziqi Xu, Fei Liu, Wei Qian · 2020 · Aging
11. New Insights Into the Biology of Protein O-GlcNAcylation: Approaches and Observations
    Toni Mueller, Xiaosen Ouyang, Michelle Smith Johnson, Weijun Qian, John C. Chatham, Victor M. Darley-Usmar, Jianhua Zhang · 2021 · Frontiers in Aging
12. Emerging roles of O-GlcNAcylation in protein trafficking and secretion
    Jianchao Zhang, Yanzhuang Wang · 2024 · Journal of Biological Chemistry
13. Inducible lectins and plant resistance to pathogens and abiotic stress
    Alexander V. Babosha · 2008 · Biochemistry (Moscow)
14. Glycation vs. glycosylation: a tale of two different chemistries and biology in Alzheimer’s disease
    Naoyuki Taniguchi, Motoko Takahashi, Yasuhiko Kizuka, Shinobu Kitazume, Vladimir V. Shuvaev, Tomomi Ookawara, Akiko Furuta · 2016 · Glycoconjugate Journal
15. Enzyme Molecular Mechanism as a Starting Point to Design New Inhibitors: A Theoretical Study of O-GlcNAcase
    Jerônimo Lameira, Cláudio Nahum Alves, Iñaki Tuñón, Sergio Martı́, Vicent Moliner · 2011 · The Journal of Physical Chemistry B
16. Hourly analysis of cerebrospinal fluid glucose shows large diurnal fluctuations
    Marcel M. Verbeek, Wilhelmina G. Leen, Michèl A.A.P. Willemsen, Diane Slats, Jurgen A.H.R. Claassen · 2016 · Journal of Cerebral Blood Flow & Metabolism
17. Altered O-GlcNAcylation and mitochondrial dysfunction, a molecular link between brain glucose dysregulation and sporadic Alzheimer’s disease
    Chia‐Wei Huang, Nicholas C. Rust, Hsueh‐Fu Wu, Gerald Warren Hart · 2022 · Neural Regeneration Research
18. A Quantum Mechanics/Molecular Mechanics Study of the Protein−Ligand Interaction of Two Potent Inhibitors of Human O-GlcNAcase: PUGNAc and NAG-Thiazoline
    Jerônimo Lameira, Cláudio Nahum Alves, Vicent Moliner, Sergio Martı́, Natalia Kanaan, Iñaki Tuñón · 2008 · The Journal of Physical Chemistry B
19. The function of GluR1 and GluR2 in cerebellar and hippocampal LTP and LTD is regulated by interplay of phosphorylation andO‐GlcNAc modification
    Nasirud Din, Ishtiaq Ahmad, Ikram ul Haq, Sana Elahi, Daniel C. Hoessli, Abdul Rauf Shakoori · 2010 · Journal of Cellular Biochemistry
20. Cyclooxygenase-2 is critical for the propagation of β-amyloid protein and reducing the glycosylation of tau in Alzheimer’s disease
    Pei-Pei Guan, Xin Yu, Yan-Hui Zou, Pu Wang · 2019 · Cellular and Molecular Immunology
21. The Glucose Metabolic Pathway as A Potential Target for Therapeutics: Crucial Role of Glycosylation in Alzheimer’s Disease
    Vidyasagar Naik Bukke, Rosanna Villani, Archana Moola, Agata Wawrzyniak, Krzysztof Balawender, Stanisław Orkisz, Luca Ferraro, Gaetano Serviddio, Tommaso Cassano · 2020 · International Journal of Molecular Sciences
22. Calpain I Activation Causes GLUT3 Proteolysis and Downregulation of O-GlcNAcylation in Alzheimer’s Disease Brain
    Jianlan Gu, Nana Jin, Denglei Ma, Dandan Chu, Khalid Iqbal, Cheng‐Xin Gong, Fei Liu · 2018 · Journal of Alzheimer s Disease
23. Therapeutic potential of rescuing protein O-GlcNAcylation in tau-related pathologies
    Fabio Di Domenico, Chiara Lanzillotta, Antonella Tramutola · 2018 · Expert Review of Neurotherapeutics
24. Post-Translational Modifications in Alzheimer's Disease and the Potential for New Biomarkers
    Claire L. Russell, Saša Končarević, Malcolm Andrew Ward · 2014 · Journal of Alzheimer s Disease
25. Understanding Alzheimer's disease by global quantification of protein phosphorylation and sialylated N-linked glycosylation profiles: A chance for new biomarkers in neuroproteomics?
    Pernille S. Lassen, Camilla Thygesen, Martin R. Larsen, Stefan J. Kempf · 2017 · Journal of Proteomics
26. SIRT1 deficiency increases O-GlcNAcylation of tau, mediating synaptic tauopathy
    Xiaomin Yin, Yuanyuan Li, Xing Fan, Fang Huang, Yanyan Qiu, Chenhao Zhao, Zheng Zhou, Qun Gu, Liye Xia, Junze Bao et al. · 2022 · Molecular Psychiatry
27. Functional Implications of O-GlcNAcylation-dependent Phosphorylation at a Proximal Site on Keratin 18
    Poonam S. Kakade, Srikanth Budnar, Rajiv D. Kalraiya, Milind M. Vaidya · 2016 · Journal of Biological Chemistry
28. Therapeutic and diagnostic challenges for frontotemporal dementia
    Simon Dâ€TMAlton, Jada M. Lewis · 2014 · Frontiers in Aging Neuroscience
29. The Significance of Tau Aggregates in the Human Brain
    Rudy J. Castellani · 2020 · Brain Sciences
30. Tau Phosphorylation and Aggregation as a Therapeutic Target in Tauopathies
    Nahuai Badiola, Marc Suárez‐Calvet, Alberto Lleó · 2010 · CNS & Neurological Disorders - Drug Targets
31. The hexosamine signaling pathway: a new road to drug discovery
    Stephen Marshall · 2002 · Current Opinion in Endocrinology & Diabetes
32. Hexosamine biosynthetic pathway and O-GlcNAc cycling of glucose metabolism in brain function and disease
    Dong Yeol Kim, Ji‐Won Park, Inn‐Oc Han · 2023 · American Journal of Physiology-Cell Physiology
33. O-GlcNAcase contributes to cognitive function in Drosophila
    Villő Muha, Michaela Fencková, Andrew T. Ferenbach, Marica Catinozzi, Ilse Eidhof, Erik Storkebaum, Annette Schenck, Daan M. F. van Aalten · 2020 · Journal of Biological Chemistry
34. Effect of O-Linked Glycosylation on the Equilibrium Structural Ensemble of Intrinsically Disordered Polypeptides
    Gül H. Zerze, Jeetain Mittal · 2015 · The Journal of Physical Chemistry B
35. Intracellular glycosylation and development
    Niall O'Donnell · 2002 · Biochimica et Biophysica Acta (BBA) - General Subjects
36. The post-translational modification O-GlcNAc is a sensor and regulator of metabolism
    Murielle M. Morales, Matthew R. Pratt · 2024 · Open Biology
37. Diazaspirononane Nonsaccharide Inhibitors of O-GlcNAcase (OGA) for the Treatment of Neurodegenerative Disorders
    Carlos M. Martínez‐Viturro, Andrés A. Trabanco, Jordi Royes, Elena Fernández, Gary Tresadern, Juan A. Vega, Alcira del Cerro, Francisca Delgado, Aránzazu García Molina, Fulgencio Tovar et al. · 2020 · Journal of Medicinal Chemistry
38. Targeting Tau to Treat Clinical Features of Huntington's Disease
    Maria Masnata, Shireen Salem, Aurélie de Rus Jacquet, Mehwish Anwer, Francesca Cicchetti · 2020 · Frontiers in Neurology
39. Deciphering the Functions of O-GlcNAc Glycosylation in the Brain: The Role of Site-Specific Quantitative O-GlcNAcomics
    John W. Thompson, Alexander W. Sorum, Linda C. Hsieh‐Wilson · 2018 · Biochemistry
40. Molecular Connection Between Diabetes and Dementia
    Yanxing Chen, Qian Yu, Cheng‐Xin Gong · 2019 · Advances in experimental medicine and biology
41. O-GlcNAc Glycosylation and Neurological Disorders
    Tony Lefebvre, Marie‐Laure Caillet‐Boudin, Luc Buée, André Delacourte, Jean‐Claude Michalski · 2003 · Advances in experimental medicine and biology
42. Regulation of AβPP Glycosylation Modification and Roles of Glycosylation on AβPP Cleavage in Alzheimer’s Disease
    Peng-Fei Tao, Han‐Chang Huang · 2019 · ACS Chemical Neuroscience
43. Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer’s Disease
    Amy R. Nelson · 2022 · Frontiers in Aging Neuroscience
44. Distinct patterns of plaque and microglia glycosylation in Alzheimer's disease
    Caitlyn Fastenau, Madison Bunce, Mallory Keating, Jessica L. Wickline, Sarah C. Hopp, Kevin F. Bieniek · 2024 · Brain Pathology
45. Computational Analysis of Human OGA Structure in Complex with PUGNAc and NAG-Thiazoline Derivatives
    Nelson Alencar, Paulo Robson Monteiro de Sousa, José Rogério A. Silva, Jerônimo Lameira, Cláudio Nahum Alves, Sergio Martı́, Vicent Moliner · 2012 · Journal of Chemical Information and Modeling
46. Glycobiology in the field of aging research—introduction to glycogerontology
    Akira Kobata · 2003 · Biochimie
47. Recent advances in experimental modeling of the assembly of tau filaments
    Li‐wen Ko, Michael A. Deture, Naruhiko Sahara, Rifki Chihab, Irving E. Vega, Shu-Hui C. Yen · 2004 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
48. Design and synthesis of naphthalimide group-bearing thioglycosides as novel β-N-acetylhexosaminidases inhibitors
    Shengqiang Shen, Wei Chen, Lili Dong, Qing Kun Yang, Huizhe Lu, Jianjun Zhang · 2018 · Journal of Enzyme Inhibition and Medicinal Chemistry
49. Protein O-GlcNAcylation: Potential Mechanisms for the Regulation of Protein Function
    Bradley K. Hayes, Gerald Warren Hart · 1998 · Advances in experimental medicine and biology
50. Modification of the Thioglycosyl–Naphthalimides as Potent and Selective Human O-GlcNAcase Inhibitors
    Shengqiang Shen, Lili Dong, Wei Chen, Xiangdi Zeng, Huizhe Lu, Qing Yang, Jianjun Zhang · 2018 · ACS Medicinal Chemistry Letters
51. Prion-Like Propagation Mechanisms in Tauopathies and Traumatic Brain Injury: Challenges and Prospects
    Hadeel Alyenbaawi, W. Ted Allison, Sue‐Ann Mok · 2020 · Biomolecules
52. Thiamme2-G, a Novel O-GlcNAcase Inhibitor, Reduces Tau Hyperphosphorylation and Rescues Cognitive Impairment in Mice
    Danmin Pan, Jin‐Hua Gu, Jin Zhang, Ya-e Hu, Fei Liu, Khalid Iqbal, Nevena Cekic, David J. Vocadlo, Chun‐Ling Dai, Cheng‐Xin Gong · 2021 · Journal of Alzheimer s Disease
53. Quantum Mechanical/Molecular Mechanical Molecular Dynamics Simulation of Wild-Type and Seven Mutants of CpNagJ in Complex with PUGNAc
    Jerônimo Lameira, Cláudio Nahum Alves, Vicent Moliner, Sergio Martı́, Raquel Castillo, Iñaki Tuñón · 2010 · The Journal of Physical Chemistry B
54. Synthesis of NAM-thiazoline derivatives as novel O-GlcNAcase inhibitors
    Hanchu Kong, Wei Chen, Tian Liu, Huizhe Lu, Qing Kun Yang, Yanhong Dong, Xiaomei Liang, Shuhui Jin, Jianjun Zhang · 2016 · Carbohydrate Research
55. Phosphorylation Pattern of tau Associated with Distinct Changes of the Growth Cone Cytoskeleton
    Goran Šimić, Andrea Diana, Patrick R. Hof · 2003 · Progress in molecular and subcellular biology
56. The Involvement of Post-Translational Modifications in Regulating the Development and Progression of Alzheimer’s Disease
    Pei-Pei Guan, Pu Wang · 2023 · Molecular Neurobiology
57. Activation of Neuronal Defense Mechanisms in Response to Pathogenic Factors Triggering Induction of Amyloidosis in Alzheimer's Disease
    Alexander V. Maltsev, Rasa Santockyte, Simon M. Bystryak, Oxana V. Galzitskaya · 2014 · Journal of Alzheimer s Disease
58. A striking common O‐linked N‐acetylglucosaminyl moiety between cruzipain and myosin
    Diana M. Acosta, Luciana L. Soprano, Maximiliano Ruben Ferrero, M. LANDONI, Mónica I. Esteva, Alicia S. Couto, Vilma Gladys Duschak · 2011 · Parasite Immunology
59. Synthesis of NAG-thiazoline-derived inhibitors for β-N-acetyl-d-hexosaminidases
    Hanchu Kong, Wei Chen, Huizhe Lu, Qing Kun Yang, Yanhong Dong, Daoquan Wang, Jianjun Zhang · 2015 · Carbohydrate Research
60. Characterization of Phosphorylation Dependent Antibodies To Study the Phosphorylation Status of the Tau Protein
    David L. Singer, Daniela Volke, Ralf Hoffmann · 2005 · International Journal of Peptide Research and Therapeutics
61. Oligodendrocyte Dysfunction in Tauopathy: A Less Explored Area in Tau-Mediated Neurodegeneration
    Moumita Majumder, Debashis Dutta · 2024 · Cells
62. Therapeutic Targets in Alzheimer's Disease and Related Tauopathies
    Christopher P. Corbo, Alejandra del C. Alonso · 2011 · Progress in molecular biology and translational science
63. O-GlcNAc modification differentially regulates microtubule binding and pathological conformations of tau isoforms in vitro
    Mohammed M. Alhadidy, Paul M. Stemmer, Nicholas M. Kanaan · 2025 · Journal of Biological Chemistry
64. Structural studies of a surface-entropy reduction mutant of O-GlcNAcase
    Alexandra Males, G.J. Davies · 2019 · Acta Crystallographica Section D Structural Biology
65. Nutrient regulation of transcription and signalling by O-GlcNAcylation
    Gerald Warren Hart · 2015 · Perspectives in Science
66. Dessert or Poison? The Roles of Glycosylation in Alzheimer's, Parkinson's, Huntington's Disease, and Amyotrophic Lateral Sclerosis
    Jiajun Yang, Hongmei Li, Yuhui Zhao · 2023 · ChemBioChem
67. Brain O-GlcNAcylation: From Molecular Mechanisms to Clinical Phenotype
    Batuhan Uygar, Olof Lagerlöf · 2022 · Advances in neurobiology
68. Unraveling the tau puzzle: a review of mechanistic targets and therapeutic interventions to prevent tau pathology in Alzheimer’s disease
    Sachin V Kammula, Sulagna Tripathi, Ning Wang, Valina Lynn Dawson, Ted M. Dawson, Xiaobo Mao · 2023 · Ageing and Neurodegenerative Diseases
69. Atomic Force Microscopy Applied to the Study of Tauopathies
    Maria do Socorro do Nascimento Amorim, Álefe Roger Silva França, Ralph Santos‐Oliveira, Jonas Rodrigues Sanches, Thamys Marinho Melo, Bruno Pinto, Leandro R.S. Barbosa, Luciana Magalhães Rebêlo Alencar · 2024 · ACS Chemical Neuroscience
70. Comprehensive Evaluation of Cleavable Bioorthogonal Probes for Site-Specific O-GlcNAc Proteomics
    Chunyan Hou, Hemeng Zhang, Jingtao Deng, Xiaoxin Wang, Stephen W. Byers, Moshe Levi, Daniel T.S. Pak, Kelley W. Moremen, Huadong Pei, Gerald Warren Hart et al. · 2025 · Molecular & Cellular Proteomics
71. Tau post-translational modifications in Alzheimer's disease: Insights into pathogenesis, therapeutic strategies, and diagnostic advances
    Hui Lei, Xiaohua Chen, Longzhu Ruan, Xuena Liu, Fei Ye, Kejing Li, Wei Cheng, Boyi Yu, Cuixia Di, Cuixia Di · 2025 · Ageing Research Reviews
72. Protein O‐GlcNAcylation in Health and Diseases
    Zhihong Ran, Chuanbao Chen, Jingfeng Ou, Guozhi Wu, Chao Yang, Xiaoyou Liu · 2025 · MedComm
73. Tau protein: Physiological functions and multifaceted roles in neurodegenerative and psychiatric disorders
    Fei Tang, Junfen Wei, Ma-Li Wong, Peng Lei · 2025 · Genomic psychiatry :
74. Enzymatic Molecular Mechanism of the Human O-GlcNAcase to Design New Inhibitors: A Quantum Mechanical Approach
    Mina Ghiasi, Zohre Hasanzade · 2014 · Journal of Carbohydrate Chemistry
75. Intensive protein synthesis in neurons and phosphorylation of beta-amyloid precursor protein and tau-protein are triggering factors of neuronal amyloidosis and Alzheimer's disease
    Alexander V. Maltsev, Nikita V. Dovidchenko, Victor Konstantinovich Uteshev, Viktoriya V. Sokolik, O. M. Shtang, M. A. Yakushin, N. M. Sokolova, Alexey K. Surin, Oxana V. Galzitskaya · 2013 · Biomeditsinskaya Khimiya
76. Production of O-GlcNAc Modified Recombinant Tau in E. coli and Detection of Ser400 O-GlcNAc Tau In Vivo
    Scott A. Yuzwa, David J. Vocadlo · 2016 · Methods in molecular biology
77. Towards an Integrated Analytical Technology for the Generation of Multidimensional Protein Expression Maps
    Paul A. Haynes, David R. Goodlett, Steven P. Gygi, Julian D. Watts, Daniel Figeys, Ruedi H. Aebersold · 2000 · Humana Press eBooks
78. Biomarkers and Target-Specific Small-Molecule Drugs in Alzheimer’s Diagnostic and Therapeutic Research: From Amyloidosis to Tauopathy
    Sheng Li, Rajiv Bhalla · 2024 · Neurochemical Research
79. Phosphorylation of Tau Protein by CDK2/cyclin A and GSK3β Recombinant Kinases: Analysis of Phosphorylation Patterns by Nuclear Magnetic Resonance Spectroscopy
    Léa El Hajjar, Clarisse Bridot, Marine Nguyen, François‐Xavier Cantrelle, Isabelle Landrieu, Caroline Smet‐Nocca · 2024 · Methods in molecular biology
80. Cell-Based Assays for Regulators of Tau Biology
    Umesh K. Jinwal, Chad A. Dickey · 2010 · Methods in molecular biology
81. Effect of Peripheral Insulin Administration on Phosphorylation of Tau in the Brain
    Yanli Jiang, Longfei Li, Chun‐Ling Dai, Ranran Zhou, Cheng‐Xin Gong, Khalid Iqbal, Jin‐Hua Gu, Fei Liu · 2020 · Journal of Alzheimer s Disease
82. The Role of Glycogen Synthase Kinase-3 (GSK-3) in Alzheimer’s Disease
    Miguel Medina, Jesus Avil · 2011 · InTech eBooks
83. DeepO-GlcNAc: a web server for prediction of protein O-GlcNAcylation sites using deep learning combined with attention mechanism
    Liyuan Zhang, Tingzhi Deng, Shuijing Pan, Minghui Zhang, Yusen Zhang, Chunhua Yang, Xiaoyong Yang, Geng Tian, Jia Dai Mi · 2024 · Frontiers in Cell and Developmental Biology
84. Molecular Mechanism of Tau Misfolding and Aggregation: Insights from Molecular Dynamics Simulation
    Haiyang Zhong, Hongli Liu, Huanxiang Liu · 2023 · Current Medicinal Chemistry
85. C. elegans Genetic Networks Predict Roles for O-GlcNAc Cycling in Key Signaling Pathways
    Michelle A. Mondoux, Michael Krause, John A. Hanover · 2010 · Current Signal Transduction Therapy
86. Somatic Cell Cycle Regulation By Histone H3 Modifications: Action of OGT and Kinases
    Afshan Kaleem, Ishtiaq Ahmad, Tayyaba Wajahat, Daniel C. Hoessli, Evelyne Walker‐Nasir, Syed Altaf Hussain, Wajahat Mahmood Qazi, Abdul Wahid Rauf · 2006
87. Targeted tau protein degradation: a promising therapeutic approach for tauopathies
    Narjes Baazaoui, Mohammad Yahya Alfaifi, Ali Abdullah Shati, Rania Ben Saad, Stefanıa Garzoli · 2025 · Neuroscience
88. Role of Tau Protein Hyperphosphorylation in Diabetic Retinal Neurodegeneration
    Jingyu Mu, Zengrui Zhang, Chao Jiang, Haoming Geng, Junguo Duan · 2025 · Journal of Ophthalmology
89. O-Linked N-Acetylglucosamine (GlcNAc) Transferase (UDP-N-Acetylglucosamine: Polypeptide-N-Acetylglucosaminyl Transferase) (OGT)
    Partha Sarathi Banerjee, Gerald Warren Hart · 2014 · Springer eBooks
90. Purification of bovine Tau versions by affinity chromatography
    Daniela Volke, Ralf Hoffmann · 2006 · Protein Expression and Purification
91. Distribution of O-GlcNAc Transferase in the Rat Pancreas.
    Yoshihiro Akimoto, Gerald Warren Hart, Hiroshi Hirano · 2000 · ACTA HISTOCHEMICA ET CYTOCHEMICA
92. Post-translational modifications as a regulatory code for tau function in health and disease
    Abigail J. Nordbeck, Bhirisha Sharma, Charles A. Garcia, Jui‐Heng Tseng · 2026 · Frontiers in Dementia
93. Stimulation of Tau Degradation
    Rodrigo A. Quintanilla, Fabian Cabezas-Opazo, Susanne P. Pallo, Adrianne S. Chesser, Gail V.W. Johnson · 2016 · Elsevier eBooks
94. The O-GlcNAc Modification of Recombinant Tau Protein and Characterization of the O-GlcNAc Pattern for Functional Study
    Léa El Hajjar, Clarisse Bridot, Marine Nguyen, François‐Xavier Cantrelle, Isabelle Landrieu, Caroline Smet‐Nocca · 2024 · Methods in molecular biology
95. Glycosylation of Proteins — A Major Challenge in Mass Spectrometry and Proteomics
    Gerald Warren Hart, Robert Norman Cole, Lisa K. Kreppel, C. Shane Arnold, Frank I. Comer, Sai Prasad N. Iyer, Xiaogang Cheng, Jill Carroll, Glendon J. Parker · 2000 · Humana Press eBooks
96. Tau protein aggregation: A therapeutic target for neurodegenerative diseases
    Aryan Duggal, Drishti Mahindru, Kirti Baghel, Sanjana Mehrotra, Vijay Kumar Prajapati · 2025 · Advances in protein chemistry and structural biology
97. Protein aggregation in health and disease: A looking glass of two faces
    Guilherme Caldas de Andrade, Michelle F. Mota, Dinarte N Moreira-Ferreira, Jerson Lima Silva, Guilherme A. P. de Oliveira, Mayra A. Marques · 2024 · Advances in protein chemistry and structural biology
98. The Prion-like Properties of Amyloid-beta Peptide and Tau: Is there Any Risk of Transmitting Alzheimer's Disease During Neurosurgical Interventions?
    Huber Padilla-Zambrano, Ezequiel García-Ballestas, Gabriel Alexander Quiñones-Ossa, Andrés E. Sibaja-Perez, Amit Agrawal, Luis Rafael Moscote‐Salazar, Manuel Menéndez‐González · 2020 · Current Alzheimer Research
99. A DNA nanoscaffold-based electrochemical assay for sensitive determination of O-GlcNAc transferase (OGT) activity and its application in cell-permeable OGT inhibitors screening
    Yanqi Qiao, Qingqing Xue, Xinmin Yue, Yang Liu, Qian Liu, Xiujie Zhao, Dening Gu, Shuo Wang, Kai Wang, Yongmei Yin et al. · 2021 · Sensors and Actuators B Chemical
100. The Aetiology of Alzheimer’s Disease: Diverse Routes into a Common Tau Pathway
     Charles R. Harrington · 2001 · Elsevier eBooks